DOT1L Inhibitor EPZ-5676

A small molecule inhibitor of histone methyltransferase with potential antineoplastic activity. Upon intravenous administration, EPZ-5676 specifically blocks the activity of the histone lysine-methyltransferase DOT1L, thereby inhibiting the methylation of nucleosomal histone H3 on lysine 79 (H3K79) that is bound to the mixed lineage leukemia (MLL) fusion protein which targets genes and blocks the expression of leukemogenic genes. This eventually leads to an induction of apoptosis in the leukemic cells bearing the MLL gene translocations. DOT1L, a non-SET domain-containing histone methyltransferase, specifically methylates H3K79 and plays a key role in normal cell differentiation and in the development of leukemia with MLL gene rearrangement on chromosome 11 and promotes the expression of leukemia-causing genes. (NCI Thesaurus)

YOU MAY ALSO LIKE

DOT1L Gene

This gene is involved in epigenetic control of gene expression.

DOT

A procedure that uses light waves to create 3-dimensional (3-D) pictures of tissues inside the body. The pictures are created by a…

Dosimetry

Measurement of radiation exposure from x-rays, gamma rays, or other types of radiation used in the treatment or detection of diseases, including…

Dosimetrist

A person who determines the proper radiation dose for treatment.

Dose-rate

The strength of a treatment given over a period of time.

Dose-limiting

Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of…